{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:15:58Z","timestamp":1788779758850,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003775","name":"Northumberland, Tyne\u00a0and Wear NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Objective cognitive impairment is a feature of Lewy body dementia (LBD), and computerised attentional tasks are commonly used as outcome measures in interventional trials. However, the reliability of these measures, in the absence of interventions, are unknown. This study examined the reliability of these attentional measures at short-term and longer-term follow-up stages. LBD patients (<jats:italic>n<\/jats:italic>\u2009=\u200936) completed computerised attentional tasks [simple and choice reaction time, and digit vigilance (SRT, CRT, DV)] at short-term (Day 0\u2013Day 5) and longer-term (4 and 12\u00a0weeks) follow-up. Intra-class correlations (ICCs) were calculated to assess test\u2013retest reliability. At short-term, the reciprocal SRT, CRT and DV mean reaction time to correct answers, the reciprocal DV coefficient of variation, and reciprocal power of attention (PoA) all showed excellent levels of reliability (all ICCs\u2009&gt;\u20090.90). The reciprocal PoA showed the highest level of reliability (ICC\u2009=\u20090.978). At longer-term follow-up, only the reciprocal PoA had excellent levels of reliability (ICC\u2009=\u20090.927). Reciprocal SRT, CRT and DV reaction time to correct answers, and the CRT coefficient of variation values, showed good levels of test\u2013retest reliability (ICCs\u2009\u2265\u20090.85). Contrary to expectations, most attentional measures demonstrated high levels of test\u2013retest reliability at both short-term and longer-term follow-up time points. The reciprocal PoA composite measure demonstrated excellent levels of test\u2013retest reliability, both in the short-term and long-term. This indicates that objective attentional tasks are suitable outcome measures in LBD studies and that the composite PoA measure may offer the highest levels of reliability.<\/jats:p>","DOI":"10.1007\/s00415-022-10977-4","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T09:03:01Z","timestamp":1643274181000},"page":"3605-3613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantifying test-retest reliability of repeated objective attentional measures in Lewy body dementia"],"prefix":"10.1007","volume":"269","author":[{"given":"Greg J.","family":"Elder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Colloby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Firbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Paul","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"issue":"4","key":"10977_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT (2014) The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 44(4):673\u2013683. https:\/\/doi.org\/10.1017\/S0033291713000494","journal-title":"Psychol Med"},{"key":"10977_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004058","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"issue":"3","key":"10977_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.60.3.387","volume":"60","author":"D Aarsland","year":"2003","unstructured":"Aarsland D, Andersen K, Larsen JP, Lolk A (2003) Prevalence and characteristics of dementia in parkinson disease: an 8-year prospective study. Arch Neurol 60(3):387\u2013392. https:\/\/doi.org\/10.1001\/archneur.60.3.387","journal-title":"Arch Neurol"},{"issue":"6","key":"10977_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837\u2013844. https:\/\/doi.org\/10.1002\/mds.21956","journal-title":"Mov Disord"},{"issue":"12","key":"10977_CR5","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22(12):1689\u20131707. https:\/\/doi.org\/10.1002\/mds.21507","journal-title":"Mov Disord"},{"issue":"11","key":"10977_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","volume":"68","author":"CF Lippa","year":"2007","unstructured":"Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF et al (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68(11):812\u2013819. https:\/\/doi.org\/10.1212\/01.wnl.0000256715.13907.d3","journal-title":"Neurology"},{"issue":"3","key":"10977_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jnnp.2002.002576","volume":"75","author":"J Bradshaw","year":"2004","unstructured":"Bradshaw J, Saling M, Hopwood M, Anderson V, Brodtmann A (2004) Fluctuating cognition in dementia with Lewy bodies and Alzheimer\u2019s disease is qualitatively distinct. J Neurol Neurosurg Psychiatry 75(3):382\u2013387","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10977_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0010-9452(08)70489-1","volume":"43","author":"C Metzler-Baddeley","year":"2007","unstructured":"Metzler-Baddeley C (2007) A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer\u2019s disease and Parkinson\u2019s disease with dementia. Cortex 43(5):583\u2013600. https:\/\/doi.org\/10.1016\/S0010-9452(08)70489-1","journal-title":"Cortex"},{"issue":"4","key":"10977_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/13854040500376831","volume":"20","author":"TJ Ferman","year":"2006","unstructured":"Ferman TJ, Smith GE, Boeve BF, Graff-Radford NR, Lucas JA, Knopman DS et al (2006) Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer\u2019s disease. Clin Neuropsychol 20(4):623\u2013636. https:\/\/doi.org\/10.1080\/13854040500376831","journal-title":"Clin Neuropsychol"},{"issue":"6","key":"10977_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archneur.58.6.977","volume":"58","author":"C Ballard","year":"2001","unstructured":"Ballard C, O\u2019Brien J, Gray A, Cormack F, Ayre G, Rowan E et al (2001) Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol 58(6):977\u2013982. https:\/\/doi.org\/10.1001\/archneur.58.6.977","journal-title":"Arch Neurol"},{"issue":"3","key":"10977_CR11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/hbm.23100","volume":"37","author":"M Firbank","year":"2016","unstructured":"Firbank M, Kobeleva X, Cherry G, Killen A, Gallagher P, Burn DJ et al (2016) Neural correlates of attention-executive dysfunction in Lewy body dementia and Alzheimer\u2019s disease. Hum Brain Mapp 37(3):1254\u20131270. https:\/\/doi.org\/10.1002\/hbm.23100","journal-title":"Hum Brain Mapp"},{"issue":"7","key":"10977_CR12","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s00415-019-09323-y","volume":"266","author":"J Schumacher","year":"2019","unstructured":"Schumacher J, Cromarty R, Gallagher P, Firbank MJ, Thomas AJ, Kaiser M et al (2019) Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer\u2019s disease: an ex-Gaussian analysis. J Neurol 266(7):1716\u20131726. https:\/\/doi.org\/10.1007\/s00415-019-09323-y","journal-title":"J Neurol"},{"issue":"10","key":"10977_CR13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1136\/jnnp.2006.093146","volume":"77","author":"K Bronnick","year":"2006","unstructured":"Bronnick K, Ehrt U, Emre M, De Deyn PP, Wesnes K, Tekin S et al (2006) Attentional deficits affect activities of daily living in dementia-associated with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 77(10):1136\u20131142. https:\/\/doi.org\/10.1136\/jnnp.2006.093146","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10977_CR14","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/mds.23896","volume":"26","author":"JM Shine","year":"2011","unstructured":"Shine JM, Halliday GM, Naismith SL, Lewis SJ (2011) Visual misperceptions and hallucinations in Parkinson\u2019s disease: dysfunction of attentional control networks? Mov Disord 26(12):2154\u20132159. https:\/\/doi.org\/10.1002\/mds.23896","journal-title":"Mov Disord"},{"issue":"1","key":"10977_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/gps.4109","volume":"30","author":"KA Wesnes","year":"2015","unstructured":"Wesnes KA, Aarsland D, Ballard C, Londos E (2015) Memantine improves attention and episodic memory in Parkinson\u2019s disease dementia and dementia with Lewy bodies. Int J Geriatr Psychiatry 30(1):46\u201354. https:\/\/doi.org\/10.1002\/gps.4109","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"10977_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000098335","volume":"23","author":"E Rowan","year":"2007","unstructured":"Rowan E, McKeith IG, Saxby BK, O\u2019Brien JT, Burn D, Mosimann U et al (2007) Effects of donepezil on central processing speed and attentional measures in Parkinson\u2019s disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord 23(3):161\u2013167. https:\/\/doi.org\/10.1159\/000098335","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"10","key":"10977_CR17","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1212\/01.wnl.0000184517.69816.e9","volume":"65","author":"KA Wesnes","year":"2005","unstructured":"Wesnes KA, McKeith I, Edgar C, Emre M, Lane R (2005) Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 65(10):1654\u20131656. https:\/\/doi.org\/10.1212\/01.wnl.0000184517.69816.e9","journal-title":"Neurology"},{"issue":"5","key":"10977_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","volume":"16","author":"C Mueller","year":"2017","unstructured":"Mueller C, Ballard C, Corbett A, Aarsland D (2017) The prognosis of dementia with Lewy bodies. The Lancet Neurology 16(5):390\u2013398. https:\/\/doi.org\/10.1016\/S1474-4422(17)30074-1","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10977_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-018-0465-9","volume":"11","author":"GJ Elder","year":"2019","unstructured":"Elder GJ, Colloby SJ, Firbank MJ, McKeith IG, Taylor JP (2019) Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial. Alzheimers Res Ther 11(1):9. https:\/\/doi.org\/10.1186\/s13195-018-0465-9","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10977_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"issue":"15","key":"10977_CR21","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"10977_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1192\/bjp.149.6.698","volume":"149","author":"M Roth","year":"1986","unstructured":"Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S et al (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698\u2013709","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10977_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1192\/bjp.177.3.252","volume":"177","author":"MP Walker","year":"2000","unstructured":"Walker MP, Ballard CG, Ayre GA, Wesnes K, Cummings JL, McKeith IG et al (2000) The clinician assessment of fluctuation and the one day fluctuation assessment scale: two methods to assess fluctuating confusion in dementia. Br J Psychiatry 177(3):252\u2013256. https:\/\/doi.org\/10.1192\/bjp.177.3.252","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10977_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000048651","volume":"13","author":"KA Wesnes","year":"2002","unstructured":"Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF et al (2002) Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 13(3):183\u2013192. https:\/\/doi.org\/10.1159\/000048651","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"7","key":"10977_CR25","doi-asserted-by":"publisher","first-page":"e0219854","DOI":"10.1371\/journal.pone.0219854","volume":"14","author":"D Liljequist","year":"2019","unstructured":"Liljequist D, Elfving B, Skavberg RK (2019) Intraclass correlation\u2014a discussion and demonstration of basic features. PLoS ONE 14(7):e0219854. https:\/\/doi.org\/10.1371\/journal.pone.0219854","journal-title":"PLoS ONE"},{"issue":"2","key":"10977_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"issue":"8","key":"10977_CR27","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1212\/WNL.54.8.1616","volume":"54","author":"MP Walker","year":"2000","unstructured":"Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O\u2019Brien JT et al (2000) Quantifying fluctuation in dementia with Lewy bodies, Alzheimer\u2019s disease, and vascular dementia. Neurology 54(8):1616\u20131625","journal-title":"Neurology"},{"issue":"1","key":"10977_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ana.23557","volume":"72","author":"E Mori","year":"2012","unstructured":"Mori E, Ikeda M, Kosaka K, Donepezil DLBSI (2012) Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol 72(1):41\u201352. https:\/\/doi.org\/10.1002\/ana.23557","journal-title":"Ann Neurol"},{"key":"10977_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.parkreldis.2019.12.005","volume":"76","author":"M Murata","year":"2020","unstructured":"Murata M, Odawara T, Hasegawa K, Kajiwara R, Takeuchi H, Tagawa M et al (2020) Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: a phase 3 randomized clinical trial. Parkinsonism Relat Disord 76:91\u201397. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.12.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10977_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","volume":"8","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K et al (2009) Memantine in patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 8(7):613\u2013618. https:\/\/doi.org\/10.1016\/S1474-4422(09)70146-2","journal-title":"Lancet Neurol"},{"issue":"3\u20134","key":"10977_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000351672","volume":"36","author":"M Ikeda","year":"2013","unstructured":"Ikeda M, Mori E, Kosaka K, Iseki E, Hashimoto M, Matsukawa N et al (2013) Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Dement Geriatr Cogn Disord 36(3\u20134):229\u2013241. https:\/\/doi.org\/10.1159\/000351672","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"10977_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JAD-161109","volume":"57","author":"MG Kramberger","year":"2017","unstructured":"Kramberger MG, Auestad B, Garcia-Ptacek S, Abdelnour C, Olmo JG, Walker Z et al (2017) Long-term cognitive decline in dementia with lewy bodies in a large multicenter, international cohort. J Alzheimers Dis 57(3):787\u2013795. https:\/\/doi.org\/10.3233\/JAD-161109","journal-title":"J Alzheimers Dis"},{"issue":"24","key":"10977_CR33","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"M Emre","year":"2004","unstructured":"Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP et al (2004) Rivastigmine for dementia associated with Parkinson\u2019s disease. N Engl J Med 351(24):2509\u20132518. https:\/\/doi.org\/10.1056\/NEJMoa041470","journal-title":"N Engl J Med"},{"issue":"12","key":"10977_CR34","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65(12):1863\u20131872. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"issue":"3","key":"10977_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9(3):417\u2013423","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10977_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1212\/WNL.62.2.181","volume":"62","author":"TJ Ferman","year":"2004","unstructured":"Ferman TJ, Smith GE, Boeve BF, Ivnik RJ, Petersen RC, Knopman D et al (2004) DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 62(2):181\u2013187","journal-title":"Neurology"},{"issue":"1","key":"10977_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jamda.2016.07.014","volume":"18","author":"A Morandi","year":"2017","unstructured":"Morandi A, Davis D, Bellelli G, Arora RC, Caplan GA, Kamholz B et al (2017) The diagnosis of delirium superimposed on dementia: an emerging challenge. J Am Med Dir Assoc 18(1):12\u201318. https:\/\/doi.org\/10.1016\/j.jamda.2016.07.014","journal-title":"J Am Med Dir Assoc"},{"issue":"20","key":"10977_CR38","doi-asserted-by":"publisher","first-page":"e2076","DOI":"10.1212\/WNL.0000000000009434","volume":"94","author":"DS Smirnov","year":"2020","unstructured":"Smirnov DS, Galasko D, Edland SD, Filoteo JV, Hansen LA, Salmon DP (2020) Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies. Neurology 94(20):e2076\u2013e2087. https:\/\/doi.org\/10.1212\/WNL.0000000000009434","journal-title":"Neurology"},{"key":"10977_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fnhum.2018.00128","volume":"12","author":"WT To","year":"2018","unstructured":"To WT, De Ridder D, Hart J Jr, Vanneste S (2018) Changing brain networks through non-invasive neuromodulation. Front Hum Neurosci 12:128. https:\/\/doi.org\/10.3389\/fnhum.2018.00128","journal-title":"Front Hum Neurosci"},{"issue":"9","key":"10977_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-014-0074-1","volume":"6","author":"GJ Elder","year":"2014","unstructured":"Elder GJ, Taylor JP (2014) Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias? Alzheimers Res Ther 6(9):74. https:\/\/doi.org\/10.1186\/s13195-014-0074-1","journal-title":"Alzheimers Res Ther"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-10977-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-10977-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-10977-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T04:31:59Z","timestamp":1655872319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-10977-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10977"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-10977-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1964, as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}